IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo - effects of anti-inflammatory pharmacotherapy

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 3, 2009, Pages 199-207

  Prause, Olof ^a   Bossios, Apostolos ^a   Silverpil, Elin ^a   Ivanov, Stefan ^a   Bozinovski, Steven ^b   Vlahos, Ross ^b   Sjöstrand, Margareta ^a   Anderson, Gary P ^b   Lindén, Anders ^a  

^a Institute of Medicine   (Sweden)

^b Department of Civil and Environmental Engineering   (Australia)

Author keywords

CD3; Cyclosporin A; Host defence; IL 17A; Innate immunity; Lung; Neutrophils; Steroids; Th 17

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; DEXAMETHASONE; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; GRAM NEGATIVE INFECTION; IN VIVO STUDY; INFLAMMATORY CELL; LOW DRUG DOSE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD3; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CYCLOSPORINE; DEXAMETHASONE; ENDOTOXINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-17; LEUKOCYTE COUNT; LUNG; LYMPHOCYTES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PULMONARY ALVEOLI; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 67349214079     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.12.005     Document Type: Article

References (37)

1. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
2. Linden A., Laan M., and Anderson G.P. Neutrophils, interleukin-17A and lung disease. Eur Respir J 25 (2005) 159-172
3. Linden A. A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling. Sci STKE 2007 (2007) re4
4. Ivanov S., and Lindén A. Th-17 cells in the lungs?. Expert Rev Resp Med 1 2 (2007) 279-293
5. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
6. Nakae S., Iwakura Y., Suto H., and Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81 5 (2007) 1258-1268
7. Nishihara M., Ogura H., Ueda N., Tsuruoka M., Kitabayashi C., Tsuji F., et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 19 (2007) 695-702
8. Ivanov S., Bozinovski S., Bossios A., Valadi H., Vlahos R., Malmhall C., et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Respir Cell Mol Biol 36 (2007) 442-451
9. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204 (2007) 995-1001
10. Shibata K., Yamada H., Hara H., Kishihara K., and Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178 (2007) 4466-4472
11. Lockhart E., Green A.M., and Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 (2006) 4662-4669
12. Laan M., Palmberg L., Larsson K., and Linden A. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 19 (2002) 534-537
13. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108 (2001) 430-438
14. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175 (2005) 404-412
15. Ivanov S., Palmberg L., Venge P., Larsson K., and Linden A. Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust. Respir Res 6 (2005) 44
16. Ferretti S., Bonneau O., Dubois G.R., Jones C.E., and Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170 (2003) 2106-2112
17. Miyamoto M., Prause O., Sjöstrand M., Laan M., Lötvall J., and Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170 (2003) 5335-5342
18. Pitout J.D.D., and Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet 8 (2008) 159-166
19. Yi E.S., Remick D.G., Lim Y., Tang W., Nadzienko C.E., Bedoya A., et al. The intratracheal administration of endotoxin: X. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo. Inflammation 20 (1996) 165-175
20. Ewart S.L., Gavett S.H., Margolick J., and Wills-Karp M. Cyclosporin A attenuates genetic airway hyperresponsiveness in mice but not through inhibition of CD4+ or CD8+ T cells. Am J Respir Cell Mol Biol 14 (1996) 627-634
21. Bozinovski S., Jones J., Beavitt S.J., Cook A.D., Hamilton J.A., and Anderson G.P. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 286 (2004) L877-L885
22. van der Velden V.H. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm 7 (1998) 229-237
23. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202 (2005) 761-769
24. Dubin P.J., and Kolls J.K. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 292 (2007) L519-L528
25. Schleimer R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 1 (2004) 222-230
26. Carlsten H., Verdrengh M., and Taube M. Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice. Inflamm Res 45 (1996) 26-30
27. Taube M., and Carlsten H. Action of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice. Inflamm Res 49 (2000) 548-552
28. Prause O., Laan M., Lötvall J., and Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462 (2003) 193-198
29. Laan M., Cui Z.H., Hoshino H., Lötvall J., Sjöstrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 4 (1999) 2347-2352
30. Cho M.L., Ju J.H., Kim K.W., Moon Y.M., Lee S.Y., Min S.Y., et al. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4(+) T cells via down-regulation of PI3 K/Akt and NF-kappaB. Immunol Lett 108 (2007) 88-96
31. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164 5 (2000) 2832-2838
32. Liu X.K., Clements J.L., and Gaffen S.L. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells 20 (2005) 339-347
33. Culpitt S.V., Maziak W., Loukidis S., Nightingale J.A., Matthews J.L., and Barnes P.J. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1635-1639
34. Hattotuwa K.L., Gizycki M.J., Ansari T.W., Jeffery P.K., and Barnes N.C. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 165 (2002) 1592-1596
35. Keatings V.M., Jatakanon A., Worsdell Y.M., and Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155 (1997) 542-548
36. Morell F., Orriols R., de Gracia J., Curull V., and Pujol A. Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax 47 (1992) 588-591
37. Stein L.M., and Cole R.P. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med 112 (1990) 822-827